Showing results (61-70 of 253) with videos related to
Sort By:
Pageof 26
Blood|August 13, 2010
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptorMichael Hudecek, Thomas M Schmitt, Sivasubramanian Baskar, et al.Nature Cell Biology|October 27, 2018
Dormant tumour cells, their niches and the influence of immunityErica T Goddard, Ivana Bozic, Stanley R Riddell, et al.Blood|November 12, 2005
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantationCarolina Berger, Mary E Flowers, Edus H Warren, et al.Frontiers in Immunology|January 4, 2021
Cytokines in CAR T Cell-Associated NeurotoxicityJuliane Gust, Rafael Ponce, W Conrad Liles, et al.Blood Advances|September 29, 2023
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLLEmily C Liang, Aya Albittar, Jennifer J Huang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expressionKristen J Radford, Cameron J Turtle, Andrew J Kassianos, et al.Blood Reviews|June 24, 2003
The graft versus leukemia response after allogeneic hematopoietic stem cell transplantationStanley R Riddell, Carolina Berger, Makoto Murata, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Adoptive transfer of allogeneic antigen-specific T cellsStanley R Riddell, Marie Bleakley, Tetsuya Nishida, et al.Blood|October 24, 2002
CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapyCarolina Berger, C Anthony Blau, Tim Clackson, et al.Bone Marrow Transplantation|June 1, 2020
Value and affordability of CAR T-cell therapy in the United StatesSalvatore Fiorenza, David S Ritchie, Scott D Ramsey, et al.Pageof 26